Focus Stocks

Facebook (FB)

Facebook (FB)


JP Morgan (JPM)

JP Morgan (JPM)


AutoZone (AZO)

AutoZone (AZO)


Yahoo (YHOO)

Yahoo (YHOO)


Apple (AAPL)

Apple (AAPL)


Featured Stories

Medtronic Reports Fourth Quarter Earnings

Medtronic Reports Fourth Quarter Earnings


Cracker Barrel Reports Earnings, Increases Guidance

Cracker Barrel Reports Earnings, Increases Guidance


Best ETFs For Facebook Exposure

Best ETFs For Facebook Exposure


Is Yum! Brands Closing in to Support?

Is Yum! Brands Closing in to Support?


Intuitive Surgical Bullish Signs

Intuitive Surgical Bullish Signs


Interleukin Genetics, Inc. to Present at Biotech Showcase™ 2012

WALTHAM, Mass.-( Business Wire )-

Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that CEO Lewis H. Bender will present at the Biotech Showcase™ 2012 at the Wyndham Parc 55 Hotel, 55 Cyril Magnin Street in San Francisco. The presentation is scheduled for Wednesday, Jan. 11 at 11:00 a.m. (PST) in the hotel’s Mission II room, located on the fourth floor. Mr. Bender will be available for one-on-one meetings with investors participating in the Biotech Showcase before and after his presentation.

About Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics’ flagship products include its proprietary PST® genetic risk panel for periodontal disease and tooth loss susceptibility sold through dentists and the Inherent Health Weight Management Genetic Test that identifies the most effective diet and exercise program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, Mass. and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). For more information, please visit http://www.ilgenetics.com.

Media:Schwartz MSL BostonJon Siegal / Kirsten Fallon, 781-684-0770interleukin@schwartzmsl.comorInvestors:Interleukin Genetics, Inc.Eliot M. Lurier, CFO, This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

TradersHuddle Search

Sponsored By:

Stock Search:


Site Search:

Loading

Copyright © 2011 TradersHuddle.com. All Rights Reserved.